Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Sihuan Pharmaceutical Holdings Group ( (HK:0460) ) has provided an announcement.
Sihuan Pharmaceutical Holdings Group announced a share repurchase plan, buying back 20 million shares at an average price of HK$0.7342 per share, reflecting a strategic move to enhance shareholder value. The company has shown significant progress in its medical aesthetics and innovative pharmaceuticals sectors, with a notable revenue increase in its medical aesthetics business and the approval of 28 new products, which are expected to positively impact future revenue and profit.
More about Sihuan Pharmaceutical Holdings Group
Founded in 2001 and listed on the Main Board of the Stock Exchange in 2010, Sihuan Pharmaceutical is an international medical aesthetics and biopharmaceutical company. It is driven by innovation with a strong research and development platform, a comprehensive product pipeline, and a robust sales system. The company aims to be a leader in the medical aesthetics and biopharmaceutical sectors in China.
YTD Price Performance: 142.00%
Average Trading Volume: 200
Technical Sentiment Signal: Sell
Current Market Cap: $890.8M
See more insights into 0460 stock on TipRanks’ Stock Analysis page.